<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02097446</url>
  </required_header>
  <id_info>
    <org_study_id>Genewel1301</org_study_id>
    <nct_id>NCT02097446</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy</brief_title>
  <acronym>GUARDIX-FL</acronym>
  <official_title>Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genewel Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genewel Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Indication: Benign tumors of ovary(mature teratoma, mucinous cystadenoma, serous
           cystadenoma)

        -  Intervention: Device ( Test group : Guardix-FL, Control group : Interceed)

        -  Primary Outcome Measure : Anti-adhesion Rate

        -  Assessment : Operative Day(Visit 2), Post-Operative Day+7days(Vist 3), Post-Operative
           Day+4weeks(Visit4), Post-Operative Day+5weeks(Visit 5)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anti-Adhesion Rate</measure>
    <time_frame>Post-Operative Day+4weeks(Second - look)</time_frame>
    <description>Adhesion yes or no</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score</measure>
    <time_frame>Post-Operative Day+4weeks(Second-look)</time_frame>
    <description>Length of Adhesion x Grade of Adhesion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Genital Diseases, Female</condition>
  <arm_group>
    <arm_group_label>GUARDIX-FL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be treated with 1 or 2 sheet of GUARDIX-FL after ovarian cystectomy(Operative Day).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interceed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be treated with 1 or 2 sheet of interceed after ovarian cystectomy(Operative Day).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Guardix-FL</intervention_name>
    <arm_group_label>GUARDIX-FL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interceed</intervention_name>
    <arm_group_label>Interceed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patients who sign the written informed consent

          2. Women aged between 18 and 44

          3. The patients who are able to participate in clinical trial during the period of study

          4. The patients without abnormal figures at the screening laboratory examination

          5. The patients expecting ovarian cystectomy for benign ovarian tumor(mature cystic
             teratoma, Mucinous cystadenoma, serous cystadenoma)

        Exclusion Criteria:

          1. The patients who took treatments with medical products which might be barrier to
             evaluate the effectiveness

          2. The patients who took medicine like other anti-adhesion, absorbable hemostat and dose
             of steroid, immunosuppressants

          3. The patients with severe drug allergy

          4. The patients with infectious disease on abdominal or pelvic cavity

          5. The patients who previously participated in another clinical trials within the past 30
             days

          6. The patients considered inappropriate for the study

          7. The pregnant

          8. The patients with severe renal disease

          9. The patients with severe systemic diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joong Sub Choi, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Hanyang University Seoul Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seong Hun Kim, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun Ho Kim, Master</last_name>
    <phone>82-10-6455-3455</phone>
    <email>junho1012@idongsung.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dan Bee Youn, Bachelor's</last_name>
    <phone>82-10-5061-3675</phone>
    <email>yzz3675@idongsung.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>133-792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hae Jeong Kim, Bachelor's</last_name>
      <phone>82-10-2987-0960</phone>
      <email>lovejunjung@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2014</study_first_submitted>
  <study_first_submitted_qc>March 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2014</study_first_posted>
  <last_update_submitted>March 24, 2014</last_update_submitted>
  <last_update_submitted_qc>March 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

